A questionnaire survey on the patient's subjective symptoms and the treatment reality of overactive bladder and hypertension.

A questionnaire survey on the patient's subjective symptoms and the treatment reality of overactive bladder and hypertension. - OASIS Project

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013835

Enrollment

10000

Registered

2014-04-30

Start date

2013-01-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive bladder / Nocturia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Study 1. 1)male and female OAB patients aged >=40 years with nocturia, evaluated using the Overactive Bladder Symptom Score [OABSS] 2)Patients who are able to understand study procedures and agree to participate in the study by written informed consent or oral informed consent. 3)Patients who are able to answer the Data query form, judged by physician. Study 2. 1)Patients who met the entry criteria for study 1, and agree to participate in the study 2. 2)IPSS-QOL score is four or more. 3)Treatment of alpha-blocker more than one month at the study 1 in patients with BPH.

Exclusion criteria

Exclusion criteria: Study 1. 1) Strong suspect of prostate cancer and any other urinary malignancy. 2) Patients with multiple sclerosis, spinal cord injury or parkinson's disease. 3) Patients with urethral stricture. 4) Patients with history of prostate surgery within six months. 5) Patients with urinary tract infection or urinary stone. 6) Patients with interstitial cystitis or chronic prostatitis. 7) Indwelling catheter or self intermittent urinary catherization 8) Any other patients who are regarded as unsuitable for this study by the investigator. Study 2. 1)Same as study 1. 2)Residual urine >=100mL

Design outcomes

Primary

Measure	Time frame
Study 1. Patients satisfaction levels for treatment of lower urinary symptom evaluated by IPSS-QOL and their quality of life (KHQ), and the relationship with their symptom described below: 1)Overactive bladder symptom score: OABSS, International Prostate Symptom Score: IPSS, Frequency volume chart: FVC 2)Blood pressure control status 3)The combination of anti-hypertensive drugs and anti-overactive bladder drugs Their symptom evaluated by OABSS, IPSS and FVC, and the relationship with their treatment status described below: 1)Blood pressure control status: presence/absence of hypertension, types of anti-hypertensive drug 2)Types of anti-hypertensive drug and anti-overactive drug and their combination. Study 2. Changes from baseline (study 1) to 3 month treatment of any intervention were evaluated and determine the relationship with each parameter.	—

Measure

Time frame

Study 1. Patients satisfaction levels for treatment of lower urinary symptom evaluated by IPSS-QOL and their quality of life (KHQ), and the relationship with their symptom described below: 1)Overactive bladder symptom score: OABSS, International Prostate Symptom Score: IPSS, Frequency volume chart: FVC 2)Blood pressure control status 3)The combination of anti-hypertensive drugs and anti-overactive bladder drugs Their symptom evaluated by OABSS, IPSS and FVC, and the relationship with their treatment status described below: 1)Blood pressure control status: presence/absence of hypertension, types of anti-hypertensive drug 2)Types of anti-hypertensive drug and anti-overactive drug and their combination. Study 2. Changes from baseline (study 1) to 3 month treatment of any intervention were evaluated and determine the relationship with each parameter.

—

Countries

Japan

Contacts

Public ContactJun Okada

Oasis project's office EPS Corporation

prj-oasis@eps.co.jp070-5553-3489

Outcome results